Gram-negative Bacterial Infection
📧 Sign up to get email alerts when something new happens for Gram-negative Bacterial Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-04Clinical Trial Update: Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections [Phase 4]
A Phase 4 trial evaluating Imipenem/Cilastatin/Relebactam for carbapenem-resistant Enterobacteriaceae infections has been withdrawn.